alendronate has been researched along with Aortic Stenosis in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, R | 2 |
| Newby, DE | 2 |
| Ralston, SH | 2 |
| Dweck, MR | 2 |
| Spiering, W | 1 |
| Mali, WP | 1 |
| de Jong, PA | 1 |
| Pawade, TA | 1 |
| Doris, MK | 1 |
| White, AC | 1 |
| Forsyth, L | 1 |
| Evans, E | 1 |
| Graham, C | 1 |
| Williams, MC | 1 |
| van Beek, EJR | 1 |
| Fletcher, A | 1 |
| Adamson, PD | 1 |
| Andrews, JPM | 1 |
| Cartlidge, TRG | 1 |
| Jenkins, WSA | 1 |
| Syed, M | 1 |
| Fujisawa, T | 1 |
| Lucatelli, C | 1 |
| Fraser, W | 1 |
| Boon, N | 1 |
| Prendergast, B | 1 |
| Sterbakova, G | 1 |
| Vyskocil, V | 1 |
| Linhartova, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| SALTIRE II: Bisphosphonates and RANKL Inhibition in Aortic Stenosis[NCT02132026] | Phase 2 | 152 participants (Actual) | Interventional | 2014-11-12 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for alendronate and Aortic Stenosis
| Article | Year |
|---|---|
Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alendronate; Aortic Valve Stenosis; Bone Density Conservation Agents; Denos | 2021 |
3 other studies available for alendronate and Aortic Stenosis
| Article | Year |
|---|---|
Response by Bing et al to Letter Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial".
Topics: Alendronate; Aortic Valve Stenosis; Denosumab; Double-Blind Method; Humans | 2021 |
Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial".
Topics: Alendronate; Aortic Valve Stenosis; Denosumab; Double-Blind Method; Humans | 2021 |
Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.
Topics: Aged; Alendronate; Aortic Valve Stenosis; Bone Density Conservation Agents; Calcinosis; Comorbidity; | 2010 |